113 -2 (88) 2026 - Sarkisova L.V., Usmonova M.S. - CHANGES IN LIPID SPECTRUM AND THEIR ANALYSIS IN PATIENTS WITH CLOMIPHENERESISTANT POLYCYSTOS OVARIAN SYNDROME

CHANGES IN LIPID SPECTRUM AND THEIR ANALYSIS IN PATIENTS WITH CLOMIPHENERESISTANT POLYCYSTOS OVARIAN SYNDROME

Sarkisova L.V. - Bukhara State Medical Institute named after Abu Ali ibn Sinа

Usmonova M.S. - Bukhara State Medical Institute named after Abu Ali ibn Sinа

Resume

This study studied the risk factors for the development of recurrent polycystic ovaries, the role of obesity in its development. For the study, 92 women with recurrent polycystic ovaries aged 19-35 years with and without obesity were studied in the control group of 20 healthy women living in the Bukhara region. According to the results of the study, in terms of lipid metabolism markers, in obese patients, compared to non-obese and conditionally healthy controls, statistically significant increases in total cholesterol, triglycerides, and AR, and statistically significant decreases in LH/FSH ratio, estradiol, prolactin, ACTH, and cortisol were found in non-obese patients, while in obese patients, insulin, AMH, total, and free testosterone were found.

Key words: recurrent polycystic lipid spectra,obesity,adrenocorticotropic hormones, thyroid hormones, prolactin, gonadotropins, autoimmune thyroiditis, hormonal contraceptives, thyroid hormones, prolactin, gonadotropins, steroid hormones.

First page

593

Last page

596

For citation:Sarkisova L.V., Usmonova M.S. - CHANGES IN LIPID SPECTRUM AND THEIR ANALYSIS IN PATIENTS WITH CLOMIPHENERESISTANT POLYCYSTOS OVARIAN SYNDROME//New Day in Medicine 2(88)2026 593-596 https://newdayworldmedicine.com/en/new_day_medicine/2-88-2026

List of References

  1. Блесманович АЕ, Петров ЮА, Алехина АГ. Синдром поликистозных яичников: классика и современные нюансы. Журнал научных статей «Здоровье и образование в XXI веке». 2018;20(4):33–37.
  2. Ведзижева ЭР, Кузнецова ИВ, Успенская ЮБ, и др. К вопросу о патогенезе репродуктивных нарушений у женщин с ожирением. Акушерство и гинекология. 2017;(6):18–25.
  3. Глухова МВ, Дразнина ТВ, Карпов ТВ, и др. Особенности клинических, гормональных и метаболических нарушений у больных с синдромом поликистозных яичников с разными типами ожирения и нормальной массой тела. Управление качеством медицинской помощи. 2016;(1–2):33–37.
  4. Григорян ОР, Андреева ЕН. Синдром поликистозных яичников — отдаленные риски. Эффективная фармакотерапия. 2015;(5):20–25.
  5. Дубровина СО, Берлим ЮД, Красильникова ЛВ, и др. Прогнозирование рецидива эндометриоидных кист яичника во время первичного оперативного вмешательства. Таврический медико-биологический вестник. 2018;21(2):26–30.
  6. Зайдиева ЗС, Уруймагова АТ. Синдром поликистозных яичников: современные представления патогенеза, диагностики и лечения. Медицинский совет. 2021;(13):102–111.
  7. Levine S, Muneyyirci-Delale O. Stress-induced hyperprolactinemia: pathophysiology and clinical approach. Obstet Gynecol Int. 2018;2018:9253083. doi:10.1155/2018/9253083.
  8. Naimova NS, Karimova NN. Disharmony and its correction in premature ovarian insufficiency. Journal of Pharmaceutical Negative Results. 2022;13(Special Issue 08):3328–3332.
  9. Horm Behav. 2011 Aug;60(3):284–291. doi:10.1016/j.yhbeh.2011.06.003.
  10. Gao Y, Chen F, Kong QQ, Ning SF, Yuan HJ, Lian HY, et al. Stresses on female mice impair oocyte developmental potential: effects of stress severity and duration on oocytes at the growing follicle stage. Reprod Sci. 2016;23(9):1148–1157.
  11. Prasad S, Tiwari M, Pandey AN, Shrivastav TG, Chaube SK. Impact of stress on oocyte quality and reproductive outcome. J Biomed Sci. 2016;23:36. doi:10.1186/s12929-016-0253-4.

    file

    download